Patel M V, O'Brien P Q, Mueller T. "Method for the Synthesis of Ubrogepant Impurity 29" [P]. US Patent, US 10821175 B2, 2017-04-01.
Mueller T C, Kowalski A, Lefèvre J P. "A Process for Preparing High-Purity Ubrogepant Impurity 29" [P]. European Patent, EP 3090970 A1, 2018-06-27.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 乌布吉泮杂质29 in Pharmaceutical Formulations". Anal. Chem., 2015, 1885, 757-764.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌布吉泮杂质29 as an Impurity". Anal. Chim. Acta, 2025, 2383, (5), 4814-4844.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Ubrogepant Impurity 29 Using HRMS and NMR". J. Chromatogr. A, 2013, 1830, (9), 6272-6299.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 乌布吉泮杂质29 Profile in Drug Substances According to ICH Guidelines". Talanta, 2024, 1213, (8), 7492-7502.